摘要
目的观察老年2型糖尿病合并肺部感染患者采用盐酸氨溴索联合哌拉西林/他唑巴坦治疗的临床效果研究。方法选取该院2015年3月—2017年3月收治诊断2型糖尿病合并肺部感染老年患者94例,分两组,均哌拉西林/他唑巴坦治疗。对照组47例联合盐酸溴已新,实验组联合盐酸氨溴索。将两组患者临床疗效、症状消失时间、治疗时间与住院时间对照解析。结果实验组总有效率为91.25%,对照组为78.57%,实验组临床症状消失、用药治疗及住院时间明显少于对照组,差异有统计学意义(P<0.01)。结论对于老年2型糖尿病合并肺部感染患者采用盐酸氨溴索联合哌拉西林/他唑巴坦治疗的临床效果明显,缩短病程与住院时间效果理想。
Objective To observe the clinical effect of ambroxol hydrochloride and piperacillin/tazobactam in treatment of senile type 2 diabetes and pulmonary infection. Methods 94 cases of senile patients with type 2 diabetes and pulmonary infection in our hospital from March 2015 to March 2017 were selected, 47 cases in each group, and both groups were treated with piperacillin and tazobactam, the control group added the bromhexine hydrochloride, while the experimental group added the ambroxol hydrochloride, and the clinical curative effect, symptoms disappearance time, treatment time and length of stay were compared and analyzed. Results The total effective rate in the experimental group and in the control group was respectively 91.25% and 78.57%, and the clinical symptoms disappearance time, medication treatment time and length of stay were obviously lower than those in the control group, and the differences were statistically significant（P0.01）. Conclusion The clinical effect of ambroxol hydrochloride and piperacillin/tazobactam in treatment of senile type 2 diabetes and pulmonary infection is obvious, which can shorten the disease course and length of stay, and the effect is ideal.
出处
《糖尿病新世界》
2017年第16期21-23,共3页
Diabetes New World Magazine
关键词
盐酸氨溴索
哌拉西林/他唑巴坦
老年2型糖尿病合并肺部感染
临床疗效分析
Ambroxol h ydrochloride
P ip e ra c i l l in / tazobactam
Senile type 2 d iab etes an d p ulmon ary infection
Analysis of cl inical curat ive effect
